Background: Early and accurate detection of stress remodelling in racehorses is of utmost importance to prevent catastrophic injuries. Current imaging techniques have limitations in assessing early changes predisposing to catastrophic breakdowns. Positron emission tomography (PET) using 18 F-sodium fluoride ( 18 F-NaF) is a sensitive method for the detection of early bone turnover and may improve early recognition of subtle injuries. Objectives: To validate the clinical use of
Introduction
Musculoskeletal injuries are the most common cause of poor performance, premature retirement and catastrophic breakdown in the racing Thoroughbred [1, 2] . Most catastrophic fractures in racehorses occur at consistent anatomic locations and are secondary to stress remodelling of bone [1] [2] [3] . The metacarpo/metatarsophalangeal joints are the most common sites of acute injury in racing Thoroughbreds [2] . Scintigraphy is a sensitive imaging modality used to detect areas of stress remodelling [4] [5] [6] , but is limited by poor spatial resolution and two-dimensional (planar) imaging [7] . Recently, another nuclear medicine modality, positron emission tomography (PET), has become available for equine imaging [8, 9] . Compared with scintigraphy, PET offers cross-sectional imaging properties and higher spatial resolution. One of the PET tracers, 18 F-sodium fluoride (NaF), is an excellent marker of bone turnover due to incorporation of the fluoride in the hydroxyapatite crystals at sites of osteoblastic activity [10] .
In human imaging, 18 F-NaF PET was shown to be useful in the detection of sites of active bone modelling in patients with foot pain of undetermined origin [11, 12] . 18 F-NaF PET detected subchondral bone lesions of the knee that were not observed using magnetic resonance imaging (MRI) [13] and allowed for early detection of osteoarthritis of the coxofemoral joint [14, 15] . Pilot data in horses indicate that 18 F-NaF PET provides additional information over other advanced imaging modalities [8] . In previous equine studies, PET and computed tomography (CT) were performed under two separate anaesthetic episodes due to concerns over potential radiation safety issues for personnel involved in the procedure [8, 9] . However, initial data revealed that both procedures could be undertaken during a single anaesthetic episode without excessive radiation exposure to attending personnel.
The goals of the current study were to validate a clinical protocol for performing PET and CT during the same anaesthetic episode, to describe the findings of 18 F-NaF imaging in the fetlocks of Thoroughbred racehorses and to compare PET findings with scintigraphy, CT, MRI and clinical findings. We hypothesised that PET would identify focal areas of increased radiopharmaceutical uptake (IRU) in specific areas prone to stress remodelling and subsequent catastrophic breakdown, and that these findings may not be detected using other imaging modalities.
Materials and methods

Animals
Nine Thoroughbred horses actively training or recently retired from racing were studied. Signalment and racing history are provided in Supplementary Item 1. Horses 1-6 were used to validate the clinical PET/ CT protocol and were residents of the research herd at our institution. All six were either recently retired from racing or currently in training for pharmacological research. Horse 6 was subjected to euthanasia and a necropsy was performed. Horses 7-9 were privately owned clinical cases in race training and presented for lameness evaluation. A full clinical evaluation was performed for all horses. A lameness examination was performed prior to imaging.
PET/CT acquisition
PET and CT images were acquired under general anaesthesia. A systemic dose of~20 mCi (740 MBq) of Imaging was performed  with a portable veterinary PET scanner (pPET-D22) a with a 22.5 cm diameter bore, 22 cm axial field of view and 2 mm spatial resolution. Acquisition time for each anatomical area was 10-12 min.
PET images were reconstructed in a 24 cm field of view with a 300 9 300 9 288 matrix using the Brain Biosciences standard iterative Maximum Likelihood Expectation Maximisation algorithm with an isotropic 0.8 9 0.8 9 0.8 mm 3 voxel [16] . CT imaging was performed immediately after the PET scan during the same anaesthetic episode. A 16-slice GE LightSpeed scanner b was used with 140 kVp and 250 mA. Images were reconstructed with a 20-30 cm field of view, 512 9 512 matrix size and 0.6 mm thick slices using a bone algorithm.
Scintigraphy
All horses had scintigraphy performed within 1 month of PET. Lateral and dorsal images of the fetlocks were acquired with a gamma camera (IS2) c approximately 2-3 h after intravenous injection of 6.7 GBq 99m TechnetiumMethyldiphosphonate using a 1-min static mode acquisition.
Magnetic resonance imaging
Standing MRI was performed on five fetlocks from three horses within 2 weeks of PET using a dedicated 0.27T MRI scanner d . Fetlocks were selected for MRI based on the presence of PET abnormalities. A standard clinical protocol including a combination of T1-weighted, T2-weighted and STIR sequences in different imaging orientations was used.
Post-mortem evaluation
One horse was subjected to euthanasia 2 weeks after PET was performed. Oxytetracycline e (25 mg/kg i.v. diluted in saline and administered over 1 h) was administered twice (12 and 5 days prior to euthanasia) to label bone forming surfaces for histological observation. Specimens were dissected and assessed using gross necropsy, micro CT f and histology. Micro-CT acquisition was performed using 70 kVp, 114 lA, 400 ms exposure time
Multiplanar reformatted 18 F-NaF PET images of three fetlocks (sagittal, transverse and dorsal from top to bottom) illustrating different proximal sesamoid bone lesions. a), b), c) (horse 6 left hindlimb): Marked focal uptake is located in the subchondral bone of the dorsoaxial aspect of the lateral proximal sesamoid bone at the level of the middle of the body. d), e), f) (horse 3 right forelimb): Focal uptake is located at the abaxial border of the medial proximal sesamoid bone at the level of the middle of the body. g), h), i) (horse 6 left forelimb): Marked focal uptake is located at the apex of the medial proximal sesamoid bone. and a 37 lm voxel size. Five micrometre thick decalcified sections were obtained for haematoxylin-and eosin-staining and were examined using transmitted white light microscopy. Fifty micrometre thick non-decalcified histological sections were examined for bone label deposition using epifluorescent microscopy.
Image analysis
The PET images were co-registered with the CT images using 3D visualisation and analysis software (Amira) g and fused using a DICOM viewer (Horos) h for image analysis. The PET and scintigraphic images were reviewed independently by three board certified radiologists. These observers were blinded to the clinical findings. One of the radiologists reviewed the PET and scintigraphic data twice independently at least 1 month apart. Different anatomical areas were defined as follows. For scintigraphic images, the fetlock was divided in four areas: proximal phalanx, distal third metacarpal/metatarsal bone and lateral and medial proximal sesamoid bones. For the PET images, the distal metacarpal/ tarsal bone (MC3/MT3) and the proximal phalanx were further divided in four regions: dorsolateral, dorsomedial, palmaro/plantarolateral and palmaro/plantaromedial. Radiopharmaceutical uptake in each area was subjectively graded as normal (0), mild (1), or moderate to severe (2) . A final grade was defined as the median of the grades from the three radiologists.
For each area with increased uptake, nonattenuation corrected maximal standardised uptake value (SUVmax) was measured. SUV was defined as the tissue concentration of tracer divided by the decay-corrected injected activity and body weight. The Horos circular ROI tool was used and the ROI were drawn centred on the area of the highest uptake. A second similarly shaped and sized ROI was drawn on the same image in an area, in the same bone, where subjectively normal uptake was present (Supplementary Item 2).
The CT and MRI images were reviewed by one radiologist, independently of the PET and scintigraphic findings, using the designated anatomical areas. CT abnormalities were graded as absent (0), or present (1) if sclerosis, bone resorption, periarticular remodelling, or bone fragmentation was observed.
For each imaging modality, a total score equal to the sum of all scores of all ROIs were calculated for each fetlock. The fused PET and CT images were then reviewed by one radiologist to specifically localise focal 18 F-NaF uptake. 
Data analysis
Weighted kappa statistics were calculated to assess inter and intraobserver agreement for scintigraphy and PET grades. Pearson or Spearman correlations, as appropriate for the normal or non-normal data distribution respectively, between PET, scintigraphy and CT (but not MRI due to selection bias and low numbers) scores with lameness scores were examined. Normality of data was examined using the D'Agostino and Pearson normality test. For lameness correlations, data from a single limb with the highest imaging score per horse were used. Statistical significance was set at a = 0.05.
Results
Clinical findings
Lameness ranged from none (three horses) to 3/5 and was localised to a fetlock in three horses (Supplementary Item 3) . No complications during anaesthesia or recovery were observed. The median anaesthesia time from induction to transport to the recovery stall was 135 min (range, 95-155). Moderate to severe uptake (grade 2) in a proximal sesamoid bone was typically in one of three locations: the subchondral bone of dorsal axial articular surface (two lateral proximal sesamoid bones, both associated with grade 2 uptake of the palmar aspect of the lateral metacarpal condyle), the abaxial border at the level of the middle of the body (midbody) (one lateral, one medial), or the apex (2 medial) (Fig 1) . The palmar/ plantar metacarpal/tarsal condylar uptake was typically present at the centre of the condyle (Fig 2) .
PET
The median SUVmax of normal bone was 4.9 (range, 1.0-9.6), while the median SUVmax of lesions was 10.3 (2.0-37.9), leading to SUVmax ratios of 2.5 (1.3-14.0) for lesions. The highest values were associated with palmar metacarpal condylar lesions.
Scintigraphy
Eleven of the 20 fetlocks had abnormal scintigraphic uptake (Supplementary Item 5) . The most common sites of increased uptake were MC3/MT3 (6/20) and the lateral proximal sesamoid bone (6/20) . Six of the fetlocks considered normal on scintigraphy had increased uptake on PET, including one fetlock with a grade 2 lesion of the medial proximal sesamoid bone and one with biaxial grade 2 lesions of the metacarpal condyle. One fetlock had a mild uptake in the lateral proximal sesamoid bone but no evidence of PET or CT abnormality. Comparative PET and scintigraphic images are provided in Figure 3 .
CT CT detected at least one abnormality in 17 of the 20 fetlocks (Supplementary Item 6), with sclerosis or periarticular modelling being the most prominent features. The two focal grade 2 PET lesions at the abaxial border of the proximal sesamoid bones were not identified on CT (Fig 4) . One horse had no abnormality recognised in the sesamoid bone, whereas the other had enlarged vascular channels in both proximal sesamoid bones. The grade 2 lesions identified on PET in the axial border of the subchondral region of the lateral proximal sesamoid bones were not recognised on CT. All PET lesions in the palmar/plantar aspect of the metacarpal/metatarsal condyles had CT evidence of sclerosis surrounding subchondral lucencies. Palmar condylar sclerosis was identified in four fetlocks without evidence of increased PET uptake. Proximal phalangeal dorsoproximal fragments were identified on CT images in three fetlocks, with concurrent grade 2 PET uptake in two fetlocks from one horse and grade 1 PET uptake in another horse. The fetlock with the lower PET uptake had the most severe fragmentation on CT.
MRI
Abnormalities were identified on MRI of four of the five imaged fetlocks. The most common abnormalities were sclerosis (3/5 fetlocks) and osteophytosis (3/5 fetlocks). No MRI abnormalities were associated with grade 2 PET mid-body abaxial medial proximal sesamoid bone lesion (Fig 4) . In two fetlocks with PET uptake at the palmar condyles, MRI revealed sclerosis and mild STIR hyperintensity at this location in only one of the two cases (Fig 5) . In a fetlock with increased PET uptake in the subchondral bone of the proximal phalanx and MC3, MRI revealed mild periarticular modelling but did not identify subchondral changes.
Statistical analysis
There were significant correlations between scintigraphic and PET scores (P = 0.027, Spearman r = 0.49) and between CT and PET scores (P = 0.006, Spearman r = 0.70), but not between CT and scintigraphic scores (P = 0.151). The interobserver agreement scores were higher for PET scores (Kappa-weighted 0.40 [0.36-0.44], median [range]) than for scintigraphy scores (0.27 [0.17-0.47]). The intra-observer agreement for PET scores (Kappa-weighted 0.63) was also higher than for scintigraphy scores (0.58).
Three out of the nine horses had lameness localised to a fetlock. A significant correlation was observed between the lameness score and the scintigraphy score (P = 0.003, Pearson r = 0.855) and PET score (P = 0.023, Pearson r = 0.737), but not with the CT score (P = 0.206). 18 F-NaF PET lateral a) and dorsal b) maximal intensity projections and scintigraphic lateral c) and dorsal d) images of horse 6 left front fetlock. Lateral is to the left. PET uptake is marked at the apex of the medial proximal sesamoid bone (short arrow) and the palmar aspect of the lateral condyle (long arrow), and mild in the subchondral bone of the middle of the body of the proximal sesamoid bones and the palmar aspect of the medial metacarpal condyle (arrow heads). The only abnormal scintigraphic finding is mild increased uptake in the condyle region (arrow).
Post-mortem
Gross: Necropsy of Horse 6 confirmed that the left forelimb fetlock was the most severely affected with severe synovitis, periarticular modelling of the proximal sesamoid bones including apical fragmentation of the medial bone, fragmentation of the dorsoproximal aspect of the proximal phalanx and subtle subchondral bruising of the lateral metacarpal condyle without associated osteochondral defect. The hindlimb fetlocks also had mild subchondral discoloration (bruising) of the lateral aspect of the condyle without osteochondral defects. Bone discoloration was also identified in the subchondral bone on gross section of the hindlimb lateral proximal sesamoid bone axial aspect of the mid-body (Fig 6) .
Micro CT:
The microCT images demonstrated that the areas of marked 18 F-NaF uptake corresponded to focal areas of decreased bone density with large resorption cavities within a region of sclerosis (Figs 6 and 7) . Histology: Focal regions of bone resorption, with irregularly shaped and enlarged vascular spaces, were identified on histology in areas of marked 18 F-NaF. The vascular spaces typically contained peripherally palisading osteoblasts, connective tissue, vascular structures and nerves. The samples labelled with oxytetracycline revealed double fluorescent lines at the periphery of the vascular canals, indicating active osteoblastic activity (Fig 7) .
Discussion
This study demonstrated that both PET and CT imaging can be performed in a horse during a single anaesthetic episode of reasonable duration. PET findings were consistent with the locations of common Thoroughbred racehorse fetlock lesions. uptake was associated with microCT and histological evidence of vessel hyperplasia and osteoblastic activity.
The combination of PET and CT under a single anaesthetic episode was an important step towards the clinical use of this technique. In the initial PET studies [8, 9] , two anaesthetic episodes were required in order to acquire both imaging modalities. Radiopharmaceutical injection before anaesthesia not only eliminated the delay between anaesthesia induction and imaging but also facilitated a longer time between 18 F-NaF injection and image acquisition. The 1.5-2 h between injection and imaging used in this study provided better clearance of 18 F-NaF from soft tissues, compared with the 45 min in the initial study.
Anatomical localisation of lesions was clearly superior on PET images than scintigraphy images, as a result of the cross-sectional nature of the technique and spatial resolution of the scanner used. Consequently, PET has particular advantages for imaging the fetlock in racehorses because of its usefulness for not only detecting, but also discriminating between metacarpal condylar and proximal sesamoid bone lesions. The localisation of focal moderate to severe uptake of 18 F-NaF at the abaxial border at the mid-body is a pertinent finding as this is the site of a lesion that predisposes to catastrophic fracture [17] . Also the association between proximal sesamoid bone dorsoaxial subchondral uptake and lateral condylar palmar subchondral uptake in the same fetlocks is an interesting observation in consideration of the reported association between metacarpal lateral condylar fracture and axial lateral proximal sesamoid bone fracture [18] .
CT detected abnormalities in more fetlocks than PET but failed at identifying areas of increased PET uptake. This can be explained by the fundamental differences between structural and functional imaging techniques. Importantly, lameness scores significantly correlated with PET scores, but there was no significant correlation between lameness and CT. This finding indicates that PET information is useful in determining the clinical significance of CT abnormalities.
The combination of PET with CT is important for the exact localisation of lesions. However, in the current study with the strong bone signal obtained, it was possible to identify the anatomical location of the lesion without using co-registered CT images, unlike in the initial study. This improvement likely relates to the better image quality obtained with the increased duration between radiopharmaceutical injection and imaging, but also to the population of horses. Young racehorses provided better image quality due to active bone modelling, similar to what is commonly observed with scintigraphy [5] .
PET also had advantages over MRI in the current study with identification of proximal sesamoid bone lesions and subchondral bone changes not apparent on MRI. The small number of available MRI and the use of a standing low field system are limitations that need to be considered. The speed of image acquisition is another advantage of PET compared with MRI. In the current study, a total of six regions could be imaged in two hours, which would not be possible with MRI.
This study is the first to report the use of SUVmax values in horses. The values obtained are similar to those reported in the human literature [19] . The ability to quantify the activity of lesions with using SUVmax is also an interesting feature of PET when compared with the other imaging techniques. Physiological stress modelling occurs secondary to training [20] [21] [22] and the challenge is to distinguish normal adaptation from pathologic remodelling at risk for catastrophic breakdown. Based on its functional properties and quantitative abilities, PET has the potential to become an extremely useful screening tool to prevent catastrophic breakdowns. Further work is warranted to define regional differences and normal ranges of SUVmax in the Thoroughbred fetlock.
The moderate interobserver agreement observed for PET may be explained by the limited training and experience that the observers had with interpreting PET. Two of the observers had not been exposed to PET imaging prior to this study. The substantial intra-observer agreement is likely a better assessment of the technique. Also, when compared with scintigraphy, PET provided better agreement for both intra and interobserver assessments.
Limitations of the current study include the small number of horses imaged and the heterogeneous nature of our population. All horses had been in race training on the track but not all of them had previously raced. A larger study with repeated scans would be beneficial to further characterise the value of PET in a racing population. Defining appearance and SUVmax of normal fetlocks and
Sagittal PET images a), b), microCT images c), d), gross sections e), f) and decalcified H&E stained sections g), h) and undecalcified oxytetracycline labelled sections i), j) of the medial (left column) and lateral (right column) metacarpal condyles of horse 6 left front fetlock. Mild increased PET uptake in the medial condyle (long arrow) is accompanied by focal sclerosis c) and focal hyperaemia subjacent a region of mild discoloration e). Marked focal PET uptake in the lateral condyle (short arrow) is accompanied by a focal region of bone resorption subjacent a dense subchondral region of bone tissue and surrounded by a larger region of sclerosis d). Histology demonstrates enlarged and irregularly shaped vascular spaces in the lateral condyle h) compared with the medial side g). The vascular spaces contain peripherally palisading osteoblasts, connective tissue, vascular structures and nerves. Double fluorescent lines are present at the periphery of the vascular canals in the lateral condyle j) short arrow.
the evolution with race training will be the next step to enhance usefulness of PET for racehorse imaging. The requirement for general anaesthesia remains a current limitation but further development in the technology could lead to creation of PET equipment designed for imaging standing sedated horses. Reporting of radiation safety data was not an objective of this study but all scans were performed in compliance with radiation safety. The authors have carefully documented radiation exposure to the personnel involved and these data combined, with data from additional scans that have occurred since this study, will be analysed for future publication.
In conclusion, this study demonstrates the feasibility of the clinical use of PET in a racehorse population. PET has distinct advantages compared with other current imaging techniques for the detection of osseous stress related injuries. PET likely has a key role in prevention of catastrophic fractures in horseracing.
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